These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12358161)

  • 1. Comparison of average and population bioequivalence approach.
    Nakai K; Fujita M; Tomita M
    Int J Clin Pharmacol Ther; 2002 Sep; 40(9):431-8. PubMed ID: 12358161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic analysis of bioequivalence trials: implications for sex-related issues in clinical pharmacology and biopharmaceutics.
    Chen ML; Lee SC; Ng MJ; Schuirmann DJ; Lesko LJ; Williams RL
    Clin Pharmacol Ther; 2000 Nov; 68(5):510-21. PubMed ID: 11103754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel multivariate approach for estimating the degree of similarity in bioavailability between two pharmaceutical products.
    Hsu HC; Lu HL; Chan KK
    J Pharm Sci; 1995 Jun; 84(6):768-72. PubMed ID: 7562420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biometrical evaluation of bioequivalence trials using a bootstrap individual direct curve comparison method.
    Zintzaras E; Bouka P; Kowald A
    Eur J Drug Metab Pharmacokinet; 2002; 27(1):11-6. PubMed ID: 11996322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statistical aspects of bioequivalence testing between two medicinal products.
    Zintzaras E
    Eur J Drug Metab Pharmacokinet; 2005; 30(1-2):41-6. PubMed ID: 16010860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New bioequivalence studies: individual bioequivalence and population bioequivalence.
    Nakai K; Fujita M; Ogata H
    Yakugaku Zasshi; 2000 Nov; 120(11):1201-8. PubMed ID: 11190205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of direct curve comparison metrics applied to pharmacokinetic profiles and relative bioavailability and bioequivalence.
    Marston SA; Polli JE
    Pharm Res; 1997 Oct; 14(10):1363-9. PubMed ID: 9358548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial-area method in bioequivalence assessment: naproxen.
    Niazi SK; Alam SM; Ahmad SI
    Biopharm Drug Dispos; 1997 Mar; 18(2):103-16. PubMed ID: 9099447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxcarbazepine final market image tablet formulation bioequivalence study after single administration and at steady state in healthy subjects.
    Flesch G; Tudor D; Souppart C; D'Souza J; Hossain M
    Int J Clin Pharmacol Ther; 2002 Nov; 40(11):524-32. PubMed ID: 12698990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioequivalence of two oral ciprofloxacin tablets formulations.
    Cuadrado A; Gascón AR; Solinís MA; Ramírez E; Hernández RM; Knie U; Pedraz JL
    Int J Clin Pharmacol Ther; 2004 Jun; 42(6):336-41. PubMed ID: 15222727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are the current bioequivalence standards sufficient for the acceptance of narrow therapeutic index drugs? Utilization of a computer simulated warfarin bioequivalence model.
    Walker SE; Friesen MH
    J Pharm Pharm Sci; 1999; 2(1):15-22. PubMed ID: 10951658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and bioequivalence study of aniracetam after single-dose administration in healthy Chinese male volunteers.
    Tian Y; Zhang JJ; Feng SD; Zhang ZJ; Chen Y
    Arzneimittelforschung; 2008; 58(10):497-500. PubMed ID: 19025058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A limited sampling approach in bioequivalence studies: application to long half-life drugs and replicate design studies.
    Mahmood I; Mahayni H
    Int J Clin Pharmacol Ther; 1999 Jun; 37(6):275-81. PubMed ID: 10395118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of bioequivalence of a new fixed-dose combination of acarbose and metformin with the corresponding loose combination as well as the drug-drug interaction potential between both drugs in healthy adult male subjects.
    Kim S; Jang IJ; Shin D; Shin DS; Yoon S; Lim KS; Yu KS; Li J; Zhang H; Liu Y; Brendel E; Blode H; Wang Y
    J Clin Pharm Ther; 2014 Aug; 39(4):424-31. PubMed ID: 24806030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study on the bioequivalence of two formulations of pravastatin. Data from a crossover, randomised, open-label bioequivalence study in healthy volunteers.
    Almeida S; Filipe A; Almeida A; Gich I; Antonijoan R; Puntes M; Barbanoj M; Cruz Caturla M
    Arzneimittelforschung; 2006; 56(2):70-5. PubMed ID: 16572920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative bioavailability of rifampicin and isoniazid in fixed-dose combinations and single-drug formulations.
    Hao LH; Guo SC; Liu CC; Zhu H; Wang B; Fu L; Chen MT; Zhou L; Chi JY; Yang W; Nie WJ; Lu Y
    Int J Tuberc Lung Dis; 2014 Dec; 18(12):1505-12. PubMed ID: 25517820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and bioequivalence evaluation of 2 levosulpiride preparations after a single oral dose in healthy male Korean volunteers.
    Cho HY; Moon JD; Lee YB
    Int J Clin Pharmacol Ther; 2004 Mar; 42(3):174-80. PubMed ID: 15049438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics and bioequivalence assessment of a self-assembled asparaginase nanocapsule in rats].
    Yan Z; Xie J; He D; Hu X; Zhang J
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jan; 36(1):90-3. PubMed ID: 26806745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex Effect on Average Bioequivalence.
    Ibarra M; Vázquez M; Fagiolino P
    Clin Ther; 2017 Jan; 39(1):23-33. PubMed ID: 28034518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioequivalence and relative bioavailability of a new diltiazem sustained release formulation.
    Scheiwe MW; Lankhaar G; Kleinbloesem CH
    Arzneimittelforschung; 1996 Oct; 46(10):960-3. PubMed ID: 8931888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.